Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-67,486
Closed -$46.6K 6244
2026
Q1
$46.6K Sell
67,486
-207,936
-75% -$202K ﹤0.01% 5443
2025
Q4
$278K Sell
275,422
-278,142
-50% -$395K ﹤0.01% 5306
2025
Q3
$709K Sell
553,564
-2,720
-0.5% -$3.55K ﹤0.01% 4862
2025
Q2
$562K Sell
556,284
-11,098
-2% -$12.7K ﹤0.01% 4827
2025
Q1
$652K Sell
567,382
-71,701
-11% -$101K ﹤0.01% 4648
2024
Q4
$1.15M Sell
639,083
-22,530
-3% -$43.6K ﹤0.01% 4086
2024
Q3
$1.22M Sell
661,613
-6,394
-1% -$10.6K ﹤0.01% 4113
2024
Q2
$1.2M Buy
+668,007
New +$1.49M ﹤0.01% 3974

Other funds holding NVX

Israel Englander's NVX Position: Q2 2026 in Review

Israel Englander sold out of NOVONIX (NVX) in Q2 2026, closing a stake of 67,486 shares — an estimated $46.6K sold.

Israel Englander first reported a position in NVX in Q2 2024 and held it in 8 quarters. The position peaked at $1.22M in Q3 2024. 26 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

  • Israel Englander reported no remaining NOVONIX position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 67,486 NOVONIX shares in Q2 2026, an estimated $46.6K.
  • Israel Englander first reported a position in NOVONIX in Q2 2024 and held it in 8 quarters.
  • Israel Englander's NOVONIX position peaked at $1.22M in Q3 2024.
  • 26 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.